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AbstrAct
Objectives In britain, sexual health clinics (sHcs) 
are the most common location for stI diagnosis but 
many people with stI risk behaviours do not attend. 
We estimate prevalence of sHc attendance and how 
this varies by sociodemographic and behavioural factors 
(including unsafe sex) and describe hypothetical service 
preferences for those reporting unsafe sex.
Methods complex survey analyses of data from 
britain’s third National survey of sexual Attitudes and 
Lifestyles, a probability survey of 15 162 people aged 
16–74 years, undertaken 2010–2012.
Results Overall, recent attendance (past year) was 
highest among those aged 16–24 years (16.6% men, 
22.4% women), decreasing with age (<1.5% among 
those 45–74 years). Approximately 15% of sexually-
active 16–74 year olds (n=1002 men; n=1253 women) 
reported ’unsafe sex’ (condomless first sex with a new 
partner and/or ≥2 partners and no condom use, past 
year); >75% of these had not attended a sHc (past 
year). However, of non-attenders aged 16–44 years, 
18.7% of men and 39.0% of women reported chlamydia 
testing (past year) with testing highest in women aged 
<25 years. Of those aged 16–44 years reporting unsafe 
sex, the majority who reported previous sHc attendance 
would seek stI care there, whereas the majority who had 
not would use general practice.
Conclusion While most reporting unsafe sex had not 
attended a sHc, many, particularly younger women, had 
tested for chlamydia suggesting engagement with sexual 
health services more broadly. Effective, diverse service 
provision is needed to engage those at-risk and ensure 
that they can attend services appropriate to their needs.
IntROduCtIOn
Over the past 30 years, substantial changes in 
sexual behaviour in Britain have been observed 
including a decline in the age at sexual debut, larger 
numbers of partners, a wider range of sexual reper-
toires and increases in the proportion of the popu-
lation reporting same-sex sexual experiences.1 2 In 
addition, a number of strategies to improve sexual 
health and access to sexual healthcare have been 
implemented since 2000, as in other countries.3–8 
All aim to reduce risk behaviour and to improve 
access to STI testing and treatment. In an attempt to 
achieve this, genitourinary medicine (GUM) clinics 
were modernised, 48 hours waiting time targets for 
GUM implemented and the role of primary care 
expanded, resulting in an expansion in the range 
and accessibility of STI services.9 National STI-spe-
cific intervention programmes, such as chlamydia 
screening, were also implemented.10 11
Using data from the British National Surveys of 
Sexual Attitudes and Lifestyles (Natsal), we have 
previously demonstrated substantial increases 
in sexual health clinic (SHC) attendance since 
1990.9 12 Although large and increasing propor-
tions of the population are accessing sexual health 
services and testing for STIs, many people at risk 
of STIs may not. For example, in Natsal-3 (2010–
2012), two-thirds of participants in whose urine 
chlamydia was detected did not report having had 
a chlamydia test in the past year, and more than 
three-quarters had not attended a SHC during this 
time.9 Unlike surveillance data13 population-based 
probability surveys like Natsal can capture data on 
those who do not attend services, which are essen-
tial for informing the design and delivery of sexual 
health services and STI control programmes.
The aim of this study is to describe the character-
istics of SHC attenders and non-attenders reporting 
unsafe sex in the past year, as an indicator of poten-
tial need for sexual health services and to explore 
hypothetical service preference in those attending 
and not attending SHCs. This expands on our 
previous work9 by extending the age range to 74 
years and also restricting analyses to those reporting 
unsafe sex.
MethOds
Participants and procedures
Full details of the methods used in Natsal-3, a 
household-based survey, have been reported else-
where.1 14 Briefly, we used a multistage, clustered, 
stratified probability sample design. Postcode 
sectors throughout Britain were used as the primary 
sampling units (PSUs). Before selection, PSUs 
were stratified (by region, population density, 
the proportion of the population aged under 60 
and the proportion of households with a head in 
a non-manual occupation) and were then selected 
systematically with a probability of selection propor-
tional to the total number of addresses. Within each 
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sampling unit, addresses were randomly selected and trained 
interviewers visited all sampled addresses, identified individuals 
in the eligible age range and randomly selected one individual 
to invite to participate. In total, 15 162 men and women aged 
16–74 years resident in Britain were interviewed in English 
between September 2010 and August 2012 through a combina-
tion of face-to-face computer-assisted personal interviews and 
computer-assisted self-interview (CASI) for the more sensitive 
questions. Non-response to individual questions (missing data) 
was low (generally 1%–3%). Data were weighted to account for 
unequal selection probabilities in terms of age and the number 
of adults in the eligible age range at an address and differential 
non-response to correct for differences in sex, age and Govern-
ment Office Region.14–16 The Natsal-3 study was approved by 
the Oxfordshire Research Ethics Committee A (reference: 09/
H0604/27) and participants provided oral informed consent to 
take part.
Measures
In the CASI, participants were asked ‘Have you ever attended a 
SHC (GUM clinic)?’ and, if yes: ‘When was that? (The last time 
if more than once)’. Response options were: less than 1 year ago, 
between 1 and 5 years ago, between 5 and 10 years ago, more 
than 10 years ago. Participants were also asked, ‘If you thought 
that you might have an infection that is transmitted by sex, 
where would you first go to seek diagnosis and/or treatment?’. 
Response options were:
General practice (GP) surgery
Sexual health clinic (GUM clinic)
NHS Family planning clinic/contraceptive clinic/reproductive health 
clinic
NHS Antenatal clinic/midwife
Private non-NHS clinic or doctor
Pharmacy/chemist
Internet site offering treatment
Youth advisory clinic (eg, Brook clinic)
Hospital accident and emergency (A&E) department
Somewhere else
‘Sexual health clinic (GUM clinic)’ was not defined for partic-
ipants, and throughout this paper, we refer to this as ‘SHC’ for 
brevity.
In this analysis, participants were considered to have had 
‘unsafe sex’ in the past year if they reported: not using a condom 
at first sex with a new (vaginal or anal sex) partner in the past 
year and/or two or more sexual partners in the past year and no 
condom use in that time. This measure is in line with national 
clinical recommendations for those who have had unprotected 
sex with a new partner to have a sexual health check17 and 
epidemiological data on behaviours associated with increased 
risk of STIs9 among those with multiple partners. Those who 
had only had oral sex partners in the past year were not classified 
as having had unsafe sex.
statistical analysis
We used Stata V.14.1 for complex survey analysis to incorporate 
weighting, clustering and stratification of the Natsal-3 data.18 
We present prevalence estimates of SHC attendance (ever, in 
the past 5 years and in the past year) by sex (participants could 
only identify as male or female) and age group among the sexu-
ally experienced population, defined as those aged 16–74 years 
who reported at least one sexual partner ever. We then used 
logistic regression to calculate age-adjusted ORs to investigate 
how recent SHC attendance (past year) varied by key sociode-
mographic and sexual health and behaviour factors among all 
sexually active men and women (those reporting at least one 
sexual partner in the past year). We then focused our analysis 
on those reporting unsafe sex (past year) as a way of identifying 
individuals who may be at risk of STIs and who may therefore 
have a need to engage with sexual health services. Among this 
group, we used logistic regression to explore the factors associ-
ated with non-attendance at a SHC in the past year, in order to 
identify those less likely to attend. We present descriptive statis-
tics of preferred location for STI diagnosis and/or treatment 
among 16–44 year olds classified as having had unsafe sex in the 
past year (in order to ensure that the hypothetical preferences 
reflected those who were more likely to require these services in 
the future), by sex and time since last SHC attendance. Data for 
this last analysis are presented for 16–44 year olds reflecting the 
age range asked this question.
Results
Prevalence of shC attendance by age among 
sexually experienced men and women
Online supplementary appendix table 1 gives the denominators 
for different subpopulations of the sample. In total, 5707 men 
and 8218 women were sexually experienced (see online supple-
mentary appendix table 1) and just over one-fifth of these sexu-
ally experienced men (22.3%) and women (23.2%) aged 16–74 
reported ever having attended a SHC, 12% having attended in 
the past 5 years and around 5% in the past year (see figure 1 and 
online supplementary appendix table 2). There was considerable 
variation by age, with attendance highest among young people: 
19% of men and 26% of women aged 16–19 years had attended 
in the past year compared with 10% of those aged 25–29 and 
less than 1.5% of those aged 45 and over.
Patterns of shC attendance among sexually active men and 
women aged 16–74 years
Among 4819 men and 6668 women aged 16–74 years who were 
sexually active (see online supplementary appendix 1), 4.9% 
(95%CI 4.3 to 5.4) of men and 6.0% (95%CI 5.5 to 6.6) of 
women reported attending a SHC in the past year (see online 
supplementary appendix table 3). After adjustment for age, those 
who attended SHCs in the past year were more likely to report 
a range of sexual behaviours considered to be markers of STI 
risk, including multiple sexual partners and concurrency (all past 
year) and were more likely to perceive themselves at risk of STIs.
shC non-attendance among those reporting unsafe sex in the 
past year
Approximately 15% of sexually active men and women aged 
16–74 years had had unsafe sex in the past year (n=1002 and 
n=1253, respectively, see online supplementary appendix table 
1). Of the men reporting unsafe sex, 59% (95% CI 56 to 63) 
reported not using a condom at first sex with a new vaginal or 
anal sex partner in the past year, 10% (95% CI 8 to 13) reported 
two or more sexual partners in the past year and no condom use 
in that time and a further 31% (95% CI 28 to 35) reported both 
of these markers of unsafe sex. Corresponding values in women 
were 63% (95% CI 60 to 66), 6% (95% CI 5 to 9) and 30% 
(95% CI 27 to 33).
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Of those classified as having had unsafe sex, 89% of men 
and 82% of women reported not having attended a SHC in the 
past year (table 1). Non-attenders were more likely to be older 
and, among women, to report cohabiting with a partner (vs not 
being in a ‘steady’ relationship) and having no qualifications 
or only those typically gained at age 16. After adjustment for 
age, non-attenders tended to report fewer markers of risk, being 
less likely to report concurrent partnerships (among women), 
more than one sexual partner (among women) or more than two 
sexual partners (among men), one or more partnership with an 
age gap of 5 or more years (men), anal sex (women) and using 
the internet to find a sexual partner (all in the past year). Non-at-
tenders were also less likely to have had one or more partner 
who normally lives outside the UK (past 5 years) and to perceive 
themselves greatly/quite a lot at risk of STIs.
We examined chlamydia testing in the past year among 
16–44 year olds reporting unsafe sex (table 1). Of those who 
had not attended a SHC in the past year, 18.7% (15.6–22.3) 
of men and 39.0% (35.2–43.0) of women had tested for chla-
mydia in that timeframe. Chlamydia testing was significantly 
more commonly reported among those aged <25 years: 27% of 
men and 59% of women of this age who had not attended a 
SHC had been tested vs 14% of men and 27% of women aged 
25–44 years.
hypothetical service preferences for stI diagnosis/treatment 
among those reporting unsafe sex in the past year
Among 16–44 year olds reporting unsafe sex in the past year, 
around half reported that they would seek diagnosis and/
or treatment from GP if they thought they might have an STI 
(50% of men and 54% of women, table 2). However, this varied 
substantially by whether they had previously attended a SHC. 
Among those who had never attended a SHC, 65.1% of men and 
77.1% of women would seek treatment from GP. For those who 
had previously attended a SHC, SHCs were the most commonly 
preferred place of diagnosis and/or treatment, and preference 
was higher among those who had attended recently (75% of men 
and 77% of women who had attended a SHC in the past year). 
Few people would seek diagnosis and/or treatment from other 
locations.
dIsCussIOn
Approximately 1 in 20 sexually active 16–74 year olds in Britain 
reported SHC attendance in the last year. Among those who we 
defined as having had unsafe sex in the past year, 89% of men and 
82% of women had not attended a SHC during this timeframe. 
Clinic non-attenders were more likely to be older than those 
who had attended a clinic and were less likely to report other 
behaviours known to be associated with potential STI trans-
mission risk, including greater numbers of sexual partners and 
concurrent partnerships. Additionally, many of those reporting 
unsafe sex, especially those aged <25 years and particularly 
women, who had not attended a SHC had been tested for chla-
mydia in the past year. However, there remain a large propor-
tion of those reporting unsafe sex who had neither attended a 
SHC nor been tested for chlamydia in the past year indicating 
that further efforts are needed to reach those who may be at risk 
of STI acquisition or transmission. This tallies with other data 
from Natsal-3 which show that while overall, SHC attendees are 
at higher risk than non-attendees, many of those with prevalent 
chlamydia or reporting risk factors for chlamydia transmission 
had not recently tested.9 19
Much research on sexual health service use has been conducted 
within health service settings, omitting non-users of services. By 
using national probability sample survey data, we were able to 
estimate the proportion of the population not accessing SHCs. 
Furthermore, Natsal links population risk factors and service use 
behaviours, enabling us to assess the extent to which at-risk indi-
viduals access services. However, the cross-sectional nature of 
the study means that we cannot determine temporality; we do 
Figure 1 Prevalence of sexual health clinic attendance and unsafe sex (in last year) by sex and age group.
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not know whether SHC attendance preceded or followed behav-
iours known to be potential indicators of need for sexual health-
care. The data presented are representative of individuals aged 
16–74 years living in private residential households only; those 
under 16, the homeless and those living in institutions may have 
different profiles of SHC attendance and/or preferred sources 
for the diagnosis and/or treatment of STIs.
We also acknowledge limitations in our measures. First, our 
measure of SHC non-attendance does not take into account 
testing for STIs in other settings, such as primary care or 
community-based testing, which is particularly relevant for chla-
mydia and HIV as a substantial proportion of testing for these 
STIs occurs outside of SHCs.20 21 However, we have quantified 
chlamydia testing among those not attending SHC (for those 
aged <45 years on whom we have these data). Second, our two 
questions asking about SHC attendance and hypothetical service 
preference do not capture the increasing complexity of sexual 
health service provision in Britain. Given the broad range of 
settings providing SH services, we cannot be sure how partici-
pants interpreted ‘sexual health clinic (GUM clinic)’; however, 
we obtained similar estimates of SHC attendance to those from 
GUM clinic surveillance data.9 Finally, we defined those with STI 
testing needs as participants reporting (in the past year) unpro-
tected first sex with a new partner or more than one partner and 
no use of condoms. This refers to condom use for vaginal and 
anal sex since Natsal-3 did not ask about condom use during 
oral sex, which is a limitation as transmission risk for many STIs 
is determined by condomless oral sex. In addition, we acknowl-
edge that an individual’s STI risk extends beyond their own 
behaviour as it also reflects the characteristics and behaviours 
of their partner(s) and wider sexual networks. This means our 
measure will overestimate risk for some and underestimate risk 
for others. In particular, while we recognise that risks may differ 
by age and age of sexual partners, we did not have the power to 
stratify analysis by age. Nonetheless, this measure does provide 
some indicator of exposure to risk and is in line with national 
clinical recommendations for those who have had unprotected 
sex with a new partner to have a sexual health check.17
In terms of the extent of unmet sexual health need in the 
population, we found that over 85% of men and women who 
we considered to have had unsafe sex had not attended a SHC 
in the past year. While this suggests there is unmet need, the 
exact intensity of resource required to meet this need, that is, 
a comprehensive range of STI tests available from specialist 
GUM services or a chlamydia test accessed online or through 
GP, cannot be determined from these data and the take home 
message is less pessimistic.
First, those attending clinic were younger and were more 
likely to report higher-risk sexual behaviours. These are indi-
viduals who may not receive comprehensive sexual healthcare 
in primary care settings, when compared with a SHC, where 
the full range of STI tests, appropriate treatment, provider-led 
partner notification and health promotion support are more 
likely to be available,22–24 and it is encouraging that SHC use is 
higher among these key populations.
Second, many of those reporting unsafe sex and not attending 
a SHC reported testing for chlamydia in the past year, suggesting 
engagement with sexual health services more broadly. Our 
previous work suggested that most of those who test for chla-
mydia outside SHCs were at lower risk25 and may therefore 
not need the more specialist services provided by a SHC. The 
majority of people reporting unsafe sex would seek diagnosis 
and treatment for a suspected STI from GP, demonstrating the 
potential for sexual healthcare provision in primary care to reach 
those who do not attend specialist services and do not need to, 
particularly given that the majority of the British population 
are registered with a GP. Testing within GP may be increasingly 
feasible with current reconfigurations and retendering of SHCs 
across England and the drive to achieve more cost-effective ways 
of testing and treating people. Strong referral systems between 
local healthcare providers are required to ensure that those 
requiring more specialist services access them.
SHCs remain stigmatised services but qualitative research26 
shows attendance helps normalise the experience and reduces 
felt stigma and the fear of discrimination.27 Those who had more 
recently attended a SHC were more likely to report that they 
would seek care for a suspected STI at a SHC. This might be 
considered a marker of patient satisfaction provided a choice of 
services is available. At the same time, our data suggest that SHC 
providers should educate people about what to expect when they 
attend a clinic28 and normalise attendance to increase familiarity 
with SHCs. This is particularly important for those who engage 
in high-risk behaviours for STI/HIV transmission. The data do 
not allow us to investigate why people chose particular services 
and further research is required to draw conclusions about this 
and gauge satisfaction with particular sexual health services.
Although <2% of men and <1% of women would first seek 
diagnosis and/or treatment for a suspected STI from an internet 
site offering treatment, these data were collected in 2010–2012 
and online sexual health services have expanded and continue to 
do so in Britain as in other countries.29 30 eSexual Health services 
are likely to become more widely used. These may act as a triage, 
referring those at higher risk or with a positive test result. Such 
services offering diagnosis and/or treatment have been found 
to be highly acceptable to users31 and may address some of the 
barriers to SHC attendance.32
Many of the current initiatives to improve sexual health in 
Britain focus on young people, a group at highest risk of some 
sexual health outcomes such as chlamydia infection.9 19 Young 
people (16–24 years) were more likely to report SHC attendance 
(ever), despite having fewer years of being sexually active, which 
suggests that efforts to promote sexual health and service use 
in this group have had some success. Attendance at SHC was 
also higher in younger than older people reporting unsafe sex 
and in addition many young people, particularly women, who 
had not attended a SHC reported chlamydia testing. Although 
behaviours known to be associated with STI transmission, such 
as condomless sex with multiple partners, are more common 
among young people, they are not infrequently reported by men 
and women aged 25–441, and therefore sexual health and advice 
Key messages 
 ►  Approximately 1 in 20 sexually active 16–74 year olds in 
Britain reported sexual health clinic (SHC) attendance in the 
last year.
 ►  However, more than 85% of British people aged 16–74 years 
reporting ‘unsafe sex’ in the past year had not attended a 
SHC in that period. 
 ►  Although among those reporting unsafe sex, attendance 
was higher in those reporting more sexual partners and 
concurrency, both in the past year and many non-attenders 
reported testing for chlamydia in the past year.
 ►  Diverse sexual health services with strong referral 
mechanisms are needed to offer appropriate care to those at 
risk.
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services should include those open to older adults/targeted by 
risk behaviour rather than age, although not at the expense of 
services targeting young people.
People reporting behaviours that are markers of potential STI 
transmission risk were more likely to report recent SHC attend-
ance and many of those not attending SHCs reported testing 
for chlamydia. While it is encouraging that large and increasing 
proportions of the population reporting sexual behaviours 
known to be associated with STI transmission are accessing 
services, many people still do not do so. Given that non-at-
tenders reporting risk behaviours expressed preference for GP 
care, this may be an avenue for improving access to STI testing. 
However, this must be alongside improved referral from GP to 
more specialist services for patients with more complex needs 
to ensure they receive a more comprehensive package of care, 
including partner notification.
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